CAS: 137-53-1; D-Thyroxine Sodium Salt

该化合物是天然产生的甲状腺激素甲状腺素(T4)的合成钠盐衍生物,通常用于生化和制药研究,因为它在研究甲状腺激素新陈代谢,受体约束和荷尔蒙调控方面的作用.化合物具有高度纯度和稳定性,适合体外和体外应用.其水溶性有利于实验环境中精确的剂量.研究人员认为D-Thyroxine Sodium Salt值是D-Tyroxine Sodium Salt,因为它在代谢研究,激素替代调查和内分泌紊乱研究中一直保持其性能.产品通常在受控制的条件下处理,以保持其完整性和有效性.

结构式图片

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2013030282-A1
    优先权日:2011-07-18
    标题:Synthesis and characterization of near ir fluorescent magnetic and non-magnetic albumin nanoparticles for biomedical applications
    发明人:MARGEL SHLOMO; COHEN SARIT; SALKMON ENAV COREM; PELLACH MICHAL
    权利人:UNIV BAR ILAN; MARGEL SHLOMO; COHEN SARIT; SALKMON ENAV COREM; PELLACH MICHAL
    摘要:The present invention discloses Near Infrared (NIR) fluorescent albumin nanoparticles having a structure selected from a core structure or a core-shell structure. Also disclosed are a process of preparing these NIR fluorescent albumin nanoparticles, and a method of in vivo detection of pathologies, in particular cancer pathology, by using administering these NIR fluorescent albumin nanoparticles to a patient.

    专利号:US-6403576-B1
    优先权日:1998-08-24
    标题 :Antifungal and antiparasitic compounds
    发明人:JACKSON JOAN E; IWU MAURICE M; OKUNJI CHRISTOPHER O; BACCHI CYRUS; TALLY JR JOHN D; AYAFOR JOHNSON F
    权利人:US ARMY
    摘要:Novel antiparasitic and antifungal compositions are disclosed. The antiparasitic and antifungal compositions are useful for human and veterinary therapy for the treatment and/or prevention of parasitic infection. Also disclosed are novel mechanisms of identifying antifungal and antiparasitic compositions by their biochemical action on lipid synthesis and/or metabolism and/or excretion.

    专利号:US-2014315720-A1
    优先权日:2012-10-24
    标 题 :Polysaccharide ester microspheres and methods and articles relating thereto
    发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
    权利人:CELANESE ACETATE LLC
    摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Evaluation of a hypocholesterolemic agent. Dextrothyroxine sodium (Choloxin). JAMA. 1969 May 12;208(6):1014-5. Spanish. Med Times. 1965 Oct;93(10):1089-94.

    合成参考文献


    摘要:Japanese Journal of Medicine., 23(282), 1984
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知